Anti-Infectives / Critical Care

Cefrowice 500

Cefuroxime (500mg)

Cefrowice 500 pack
New LaunchRx Only

About this product

Trusted Second-Generation Cephalosporin. Established across respiratory, ENT, urinary, and skin infections.

Composition
Cefuroxime (500mg)
Cefrowice 500 composition as printed on the pack
As printed on the pack
Therapy Area
Anti-Infectives / Critical Care
Formulation
Tablet
Pack
Strip of 10
Storage
≤ 30°C

Overview

Cefrowice 500 addresses outpatient bacterial infections, and as a second-generation cephalosporin, it remains active against many beta-lactamase-producing strains. It offers established efficacy across respiratory, ENT, urinary, and skin/soft-tissue infections in everyday outpatient practice. It also provides a practical oral step-down option after initial IV cephalosporin treatment, and brings the reliability of a long-standing, well-established second-generation cephalosporin with an extensive clinical track record.

Indications

Respiratory tract infections such as pharyngitis/tonsillitis, acute bacterial sinusitis, acute bronchitis exacerbations, and mild-to-moderate community-acquired pneumonia.
Uncomplicated urinary tract infections.
Skin and soft-tissue infections.
Oral step-down therapy following initial treatment with an IV cephalosporin.
Rx only. For use under medical supervision. Intended for healthcare professionals in India.

Partner With Schemic Concepts

Engineer better health outcomes with precision-driven pharmaceuticals

Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it

Partner With Us